DAN STOKELY - 17 May 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role: CFO
Signature: /s/ Daniel Stokely
Issuer symbol: N/A
Transactions as of: 17 May 2021
Net transactions value: -$48,930
Form type: 4
Filing time: 19 May 2021, 17:56:20 UTC
Next filing: 29 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMPE	Common Stock	Options Exercise	$15,050	+35,000	+124%	$0.4300	63,315	17 May 2021	Direct
transaction	AMPE	Common Stock	Sale	$63,980	-35,000	-55%	$1.83	28,315	18 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMPE	Stock Option (Right to Buy)	Options Exercise	$0	-35,000	-11%	$0.000000	283,000	17 May 2021	Common Stock	35,000	$0.4300	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.